Cabozantinib for neurofibromatosis type 1-related plexiform neurofibromas: a phase 2 trial

Neurofibromatosis Type 1 (NF1) plexiform neurofibromas (PN) are progressive, multicellular neoplasms that cause morbidity and predispose to sarcoma. Treatment of Nf1(flox/flox);PostnCre mice with cabozantinib, an inhibitor of multiple tyrosine kinases, caused a reduction in PN size and number and di...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Nat Med
Main Authors: Fisher, Michael J., Shih, Chie-Schin, Rhodes, Steven D., Armstrong, Amy E., Wolters, Pamela L., Dombi, Eva, Zhang, Chi, Angus, Steven P., Johnson, Gary L., Packer, Roger J., Allen, Jeffrey C., Ullrich, Nicole J., Goldman, Stewart, Gutmann, David H., Plotkin, Scott R., Rosser, Tena, Robertson, Kent A., Widemann, Brigitte C., Smith, Abbi E., Bessler, Waylan K., He, Yongzheng, Park, Su-Jung, Mund, Julie A., Jiang, Li, Bijangi-Vishehsaraei, Khadijeh, Robinson, Coretta Thomas, Cutter, Gary R., Korf, Bruce R., Blakeley, Jaishri O., Clapp, D. Wade
Formato: Artigo
Idioma:Inglês
Publicado: 2021
Assuntos:
Article
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8275010/
https://ncbi.nlm.nih.gov/pubmed/33442015
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41591-020-01193-6
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares